AR222052A1 - Un procedimiento de preparacion de un derivado de espiro-policicloimidazolidindiona - Google Patents
Un procedimiento de preparacion de un derivado de espiro-policicloimidazolidindionaInfo
- Publication number
- AR222052A1 AR222052A1 AR278904A AR27890479A AR222052A1 AR 222052 A1 AR222052 A1 AR 222052A1 AR 278904 A AR278904 A AR 278904A AR 27890479 A AR27890479 A AR 27890479A AR 222052 A1 AR222052 A1 AR 222052A1
- Authority
- AR
- Argentina
- Prior art keywords
- polycylimidazolidindiona
- spiral
- derivative
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/961,335 US4181728A (en) | 1978-11-16 | 1978-11-16 | Spiro-polycyclicimidazolidinedione derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AR222052A1 true AR222052A1 (es) | 1981-04-15 |
Family
ID=25504341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR278904A AR222052A1 (es) | 1978-11-16 | 1979-11-15 | Un procedimiento de preparacion de un derivado de espiro-policicloimidazolidindiona |
Country Status (23)
Country | Link |
---|---|
US (1) | US4181728A (de) |
JP (2) | JPS6052157B2 (de) |
AR (1) | AR222052A1 (de) |
AT (1) | AT369742B (de) |
AU (1) | AU515301B2 (de) |
BE (1) | BE880065A (de) |
CA (1) | CA1125294A (de) |
CH (1) | CH642358A5 (de) |
DE (1) | DE2946037A1 (de) |
DK (1) | DK484479A (de) |
ES (1) | ES486007A1 (de) |
FI (1) | FI66385C (de) |
FR (1) | FR2441627A1 (de) |
GB (1) | GB2038315B (de) |
IE (1) | IE49116B1 (de) |
IL (1) | IL58730A (de) |
IT (1) | IT1127231B (de) |
LU (1) | LU81890A1 (de) |
NL (1) | NL177689C (de) |
PH (1) | PH15672A (de) |
PT (1) | PT70452A (de) |
SE (1) | SE447731B (de) |
YU (1) | YU41678B (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU532110B2 (en) * | 1979-11-13 | 1983-09-15 | Ici Ltd. | Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives |
ATE10940T1 (de) * | 1981-05-12 | 1985-01-15 | Imperial Chemical Industries Plc | Pyrrolderivate. |
US4464385A (en) * | 1982-04-15 | 1984-08-07 | Alcon Laboratories, Inc. | Treatment of diabetic complications with hydantoins |
US4540700A (en) * | 1982-04-15 | 1985-09-10 | Alcon Laboratories, Inc. | Treatment of diabetic complications with certain spiro-imidazolidine-diones |
JPS59500618A (ja) * | 1982-04-15 | 1984-04-12 | アルコン・ラボラトリ−ズ・インコ−ポレ−テッド | スピロ―フルオロフルオレン化合物、その製造法およびアルド―スレダクターゼ活性を阻害する組成物 |
US4438272A (en) | 1982-04-15 | 1984-03-20 | Alcon Laboratories, Inc. | Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones |
US4436745A (en) | 1982-04-15 | 1984-03-13 | Alcon Laboratories, Inc. | Method of inhibiting aldose reductase activity |
IL68314A0 (en) * | 1982-04-15 | 1983-07-31 | Alcon Lab Inc | Method and composition for inhibiting aldose reductase activity and process for preparing spirofluorofluoren and spiro-difluorofluoren compounds |
DE3342933A1 (de) * | 1983-11-26 | 1985-06-05 | Horst G. 5190 Stolberg Schumann | Regalfoerderzeug |
US4600717A (en) * | 1984-04-11 | 1986-07-15 | Alcon Laboratories, Inc. | Aldose reductase inhibitors useful in ophthalmic wound healing |
US4717725A (en) * | 1984-04-11 | 1988-01-05 | Alcon Laboratories, Inc. | Ophthalmic wound healing with aldose reductase inhibitors |
US4609663A (en) * | 1984-09-11 | 1986-09-02 | Alcon Laboratories, Inc. | Aldose reductase inhibitors useful in glaucoma therapy |
US4576143A (en) * | 1984-10-05 | 1986-03-18 | Clark Iii William T | Method of immune modification by means of extracorporeal irradiation of the blood |
US4966911A (en) * | 1984-11-20 | 1990-10-30 | Washington Research Foundation | Immunoregulatory agents |
US5340829A (en) * | 1984-11-20 | 1994-08-23 | Washington Research Foundation | Immunoregulatory agents |
JPS6372140U (de) * | 1986-10-29 | 1988-05-14 | ||
JPS63119451U (de) * | 1987-01-30 | 1988-08-02 | ||
WO1992000071A1 (en) * | 1989-02-10 | 1992-01-09 | Washington Research Foundation | Immunoregulatory agents |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2683718A (en) * | 1952-01-11 | 1954-07-13 | Searle & Co | Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione |
DE1032257B (de) * | 1954-05-27 | 1958-06-19 | Cutter Lab | Verfahren zur Herstellung neuer Hydantoine |
GB796069A (en) * | 1955-12-23 | 1958-06-04 | Ici Ltd | Substituted hydantoins |
GB818724A (en) * | 1956-10-18 | 1959-08-19 | Ici Ltd | Hydantoin derivatives |
US3532744A (en) * | 1967-07-28 | 1970-10-06 | American Home Prod | 1- and 2-amino substituted indane and tetralene carboxylic acids |
US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
US4078064A (en) * | 1976-08-18 | 1978-03-07 | E. R. Squibb & Sons, Inc. | 8H-Pyrazolo[4',3':5,6]pyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidines |
CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
US4127665A (en) * | 1978-01-18 | 1978-11-28 | Pfizer Inc. | Thienohydantoin derivatives |
-
1978
- 1978-11-16 US US05/961,335 patent/US4181728A/en not_active Expired - Lifetime
-
1979
- 1979-11-12 YU YU2773/79A patent/YU41678B/xx unknown
- 1979-11-13 GB GB7939211A patent/GB2038315B/en not_active Expired
- 1979-11-14 DE DE19792946037 patent/DE2946037A1/de not_active Ceased
- 1979-11-14 IE IE2184/79A patent/IE49116B1/en not_active IP Right Cessation
- 1979-11-14 JP JP54147592A patent/JPS6052157B2/ja not_active Expired
- 1979-11-14 PT PT70452A patent/PT70452A/pt unknown
- 1979-11-14 PH PH23277A patent/PH15672A/en unknown
- 1979-11-15 AT AT0729779A patent/AT369742B/de not_active IP Right Cessation
- 1979-11-15 NL NLAANVRAGE7908352,A patent/NL177689C/xx not_active IP Right Cessation
- 1979-11-15 AR AR278904A patent/AR222052A1/es active
- 1979-11-15 DK DK484479A patent/DK484479A/da not_active Application Discontinuation
- 1979-11-15 SE SE7909439A patent/SE447731B/sv not_active IP Right Cessation
- 1979-11-15 FI FI793586A patent/FI66385C/fi not_active IP Right Cessation
- 1979-11-15 LU LU81890A patent/LU81890A1/fr unknown
- 1979-11-15 FR FR7928234A patent/FR2441627A1/fr active Granted
- 1979-11-15 AU AU52880/79A patent/AU515301B2/en not_active Ceased
- 1979-11-15 IT IT27311/79A patent/IT1127231B/it active
- 1979-11-15 CH CH1021479A patent/CH642358A5/fr not_active IP Right Cessation
- 1979-11-15 ES ES486007A patent/ES486007A1/es not_active Expired
- 1979-11-15 IL IL58730A patent/IL58730A/xx not_active IP Right Cessation
- 1979-11-16 BE BE0/198129A patent/BE880065A/fr not_active IP Right Cessation
- 1979-11-16 CA CA340,068A patent/CA1125294A/en not_active Expired
-
1984
- 1984-10-23 JP JP59222857A patent/JPS60120870A/ja active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES494300A0 (es) | Un procedimiento para la preparacion de carboxialquil-dipep-tidos | |
ES490215A0 (es) | Un procedimiento para la preparacion de derivados de feneta-nolamina | |
ES485619A0 (es) | Un procedimiento para la preparacion de derivados de diben- zopirano | |
AR222052A1 (es) | Un procedimiento de preparacion de un derivado de espiro-policicloimidazolidindiona | |
ES490212A0 (es) | Un procedimiento para la preparacion de fenetanolaminas | |
ES491618A0 (es) | Procedimiento de preparacion de un cloro-2-propionato de al-cohilo | |
ES493111A0 (es) | Un procedimiento de preparacion de nuevas fenoxiaminas hete-rociclicas | |
ES493196A0 (es) | Un procedimiento para la preparacion de fenil-quinolicidinas | |
ES489880A0 (es) | Un procedimiento de preparacion de un trihalometilcarbonato | |
ES493544A0 (es) | Un procedimiento para la preparacion de derivados de ciclo- hexadieno | |
ES489048A0 (es) | Un procedimiento para la preparacion de derivados de hidan- toina | |
NO150995C (no) | Fremgangsmaate til fremstilling av en sekk forsynt med kryssbunn | |
ES489964A0 (es) | Un procedimiento de preparacion de derivados de la 2-fenil-4-pirona | |
ES487090A0 (es) | Procedimiento de preparacion de un derivado ciclododecano | |
AR229471A1 (es) | Procedimiento de preparacion de un derivado de alcoxi-carbonilhexil-metoxifenil piperazina | |
ES499303A0 (es) | Un procedimiento de preparacion de derivados bencilidenicos | |
NO803229L (no) | Fremgangsmaate til fremstilling av et urinstoffderivat | |
ES489648A0 (es) | Un procedimiento para la preparacion de un derivado de cefa-losporina | |
ES490617A0 (es) | Un procedimiento para la preparacion de derivados de oxadia-zolotriazona | |
ES493200A0 (es) | Un procedimiento para la preparacion de fenil-quinolicidinas | |
ES487040A0 (es) | Un derivado de 7x-metoxicefalosporina | |
ES496797A0 (es) | Un procedimiento de preparacion de derivados de azabiciclo- hexano | |
ES486832A0 (es) | Un procedimiento de produccion de derivados de 7 -metoxice- falosporina | |
AR228592A1 (es) | Procedimiento de preparacion de un derivado de un acido-benzoilureido-acetamido-cefem-carboxilico | |
ES490615A0 (es) | Un procedimiento para la preparacion de derivados de oxadia-zolotriazona |